Limba
Romanian
Romanian
English|
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT)and Abl1(T315I) with IC50of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.
| Price | 27.172,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT)and Abl1(T315I) with IC50of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1. |
